Cargando…
Reduced Expression of PLCXD3 Associates With Disruption of Glucose Sensing and Insulin Signaling in Pancreatic β-Cells
Previous work has shown that reduced expression of PLCXD3, a member of the phosphoinositide-specific phospholipases (PI-PLC) family, impaired insulin secretion with an unclear mechanism. In the current study, we aim to investigate the mechanism underlying this effect using human islets and rat INS-1...
Autores principales: | Aljaibeji, Hayat, Mukhopadhyay, Debasmita, Mohammed, Abdul Khader, Dhaiban, Sarah, Hachim, Mahmood Y., Elemam, Noha M., Sulaiman, Nabil, Salehi, Albert, Taneera, Jalal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851018/ https://www.ncbi.nlm.nih.gov/pubmed/31781030 http://dx.doi.org/10.3389/fendo.2019.00735 |
Ejemplares similares
-
Genetic Variants of the PLCXD3 Gene Are Associated with Risk of Metabolic Syndrome in the Emirati Population
por: Aljaibeji, Hayat, et al.
Publicado: (2020) -
An Integrative Phenotype–Genotype Approach Using Phenotypic Characteristics from the UAE National Diabetes Study Identifies HSD17B12 as a Candidate Gene for Obesity and Type 2 Diabetes
por: Hachim, Mahmood Y., et al.
Publicado: (2020) -
Profiling Levels of Serum microRNAs and Soluble ACE2 in COVID-19 Patients
por: Elemam, Noha Mousaad, et al.
Publicado: (2022) -
Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients
por: Elemam, Noha Mousaad, et al.
Publicado: (2021) -
EXOC6 (Exocyst Complex Component 6) Is Associated with the Risk of Type 2 Diabetes and Pancreatic β-Cell Dysfunction
por: Sulaiman, Nabil, et al.
Publicado: (2022)